Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,679 | Dovepress* | 5,258+ | 678 | 5,936 | |
PubMed Central* | 421 | 128 | 549 | ||
Totals | 5,679 | 806 | 6,485 | ||
*Since 11 May 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar